Download FREE Report Sample
Download Free sampleCovid-19 Rapid Diagnostic Test Market contains market size and forecasts of Covid-19 Rapid Diagnostic Test in Global, including the following market information:
Global Covid-19 Rapid Diagnostic Test Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Covid-19 Rapid Diagnostic Test market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immunoassay Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Covid-19 Rapid Diagnostic Test include Abbott Diagnostics, BD, Ador Diagnostics (BATM), bioM?rieux, Hardy Diagnostics, Applied BioCode, Biocartis SA, Cellmid and Akonni Biosystems, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Covid-19 Rapid Diagnostic Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Covid-19 Rapid Diagnostic Test Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Covid-19 Rapid Diagnostic Test Market Segment Percentages, by Type, 2021 (%)
Immunoassay
Genomic and WGS
rRT-PCR
Global Covid-19 Rapid Diagnostic Test Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Covid-19 Rapid Diagnostic Test Market Segment Percentages, by Application, 2021 (%)
Hospital
Laboratory
Global Covid-19 Rapid Diagnostic Test Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Covid-19 Rapid Diagnostic Test Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Covid-19 Rapid Diagnostic Test revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Covid-19 Rapid Diagnostic Test revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Diagnostics
BD
Ador Diagnostics (BATM)
bioM?rieux
Hardy Diagnostics
Applied BioCode
Biocartis SA
Cellmid
Akonni Biosystems
Alveo Technologies
Bio-Rad
Cepheid
Diasorin
Cue Health
Curetis
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy